Journal article

Targeting a unique EGFR epitope with monoclonal antibody 806 activates NF-kappa B and initiates tumour vascular normalization

Hui K Gan, Martha Lappas, Diana X Cao, Anna Cvrljevdic, Andrew M Scott, Terrance G Johns

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | WILEY | Published : 2009

DOI: 10.1111/j.1582-4934.2009.00783.x

Grants

Awarded by National Health & Medical Research Council of Australia

Funding Acknowledgements

This work was funded in part by National Health & Medical Research Council of Australia Project grant no. 433615. We thank Steven Stacker and Marc Achen for their helpful suggestions.

Citation metrics

13Web of Science
16Scopus

Keywords

Angiogenesis
Human Glioblastomas
Humans
Mice, Nude
Proinflammatory Cytokines
Female
Medicine, Research & Experimental
Epitopes
Neoplasm Transplantation
Nf-Kappa B
Egfr
Tyrosine Kinase Inhibitor
Mice
Life Sciences & Biomedicine
Human Gestational Tissues
Neovascularization, Pathologic
Research & Experimental Medicine
Cell Biology
Factor Receptor Egfr
Interleukin-8
Vascular Normalization
Cell Line, Tumor
Antibodies, Monoclonal
Neoplasms
In-Vivo
Animals
Epidermal-Growth-Factor
Vascular Endothelial Growth Factor a
Science & Technology
Receptor, Epidermal Growth Factor
Antibody Therapy
Erbb Receptors
Mutation
Squamous Carcinoma-Cells
Human-Brain-Tumors
Alpha Synthesis